spiolto

  1. E

    Spiolto Respimat shown to be superior first line therapy over LABA/ICS for COPD

    Spiolto Respimat shown to be superior first line therapy over LABA/ICS for COPD Boehringer Ingelheim today announced new data from two trials presented at the European Respiratory Society (ERS) International Congress 2015 Source: Spiolto Respimat shown to be superior first line therapy over...
Back
Top